Collectively, insulin resistance in AD underscores the intricate interplay between metabolic dysregulation and neurodegeneration, highlighting the potential therapeutic relevance of targeting insulin signaling pathways for AD prevention and treatment. Here, INS is linked to Alzheimer disease.